Compartmentation of cAMP is thought to generate the specificity of G s -coupled receptors action in cardiac myocytes, with phosphodiesterases (PDEs) playing a major role in this process by preventing cAMP diffusion. We have tested this hypothesis in adult rat ventricular myocytes (ARVMs) by characterizing PDEs involved in the regulation of cAMP signals and L-type Ca 2+ current (I Ca,L ) upon stimulation with β 1 -adrenergic receptors (β 1 -AR), β 2 -adrenergic receptors (β 2 -AR), glucagon receptors (Glu-R) and prostaglandin E 1 receptors (PGE 1 -R). All receptors but PGE 1 -R increased total cAMP, and inhibition of PDEs with IBMX strongly potentiated these responses. When monitored in single cells by high affinity cyclic nucleotide-gated (CNG) channels, stimulation of β 1 -AR and Glu-R increased cAMP, whereas β 2 -AR and PGE 1 -R had no detectable effect. Selective inhibition of PDE3 by cilostamide and PDE4 by Ro 20-1724 potentiated β 1 -AR cAMP signals, whereas Glu-R cAMP was augmented only by PD4 inhibition. PGE 1 -R and β 2 -AR generated substantial cAMP increases only when PDE3 and PDE4 were blocked. For all receptors except PGE 1 -R, the measurements of I Ca,L closely matched the ones obtained with CNG channels. Indeed, PDE3 and PDE4 controlled β 1 -AR and β 2 -AR regulation of I Ca,L , while only PDE4 controlled Glu-R regulation of I Ca,L thus demonstrating that receptor-PDE coupling has functional implications downstream of cAMP. PGE 1 had no effect on I Ca,L even after blockade of PDE3 or PDE4, suggesting that other mechanisms prevent cAMP produced by PGE 1 to diffuse to Ltype Ca 2+ channels. These results identify specific functional coupling of individual PDE families to G s -coupled receptors as a major mechanism enabling cardiac cells to generate heterogeneous cAMP signals in response to different hormones.
Introduction

Results
PDE activities in ARVMs
summarizes experiments where the relative activity of PDE2, PDE3 and PDE4 in quiescent ARVMs was determined. Total cAMP hydrolytic activity was on average 109.8±16.6 pmoles/min/mg protein (n=4) and was mainly due to PDE3 and PDE4, which represented 31% and 38% of the total, respectively. Under these assay conditions, PDE2 activity was minimal ( Fig. 1) . Immunoprecipitation experiments showed that PDE4 activity is contributed by PDE4A, PDE4B and PDE4D variants, while the PDE3A form is the predominant PDE3 expressed (data not shown). The relative activity of individual PDE families did not vary significantly after 24 h and 48 h of culture (data not shown). Moreover, the ratio of PDE3/PDE4 was similar to that measured in extracts of adult rat ventricle (data not shown). Thus, cultured ARVMs closely resemble the in vivo pattern of PDE expression.
( Figure 1 near here)
Total cAMP production in response to different GsPCRs in ARVMs
We next determined whether stimulation of different GsPCRs increased total cAMP in ARVMs (Fig. 2 ). We used a combination of isoprenaline (ISO, 5 µmol/L) and the β 2 -AR antagonist ICI 118551 (ICI, 1 µmol/L) to stimulate β 1 -AR, a combination of ISO (5 µmol/L) in the presence of the β 1 -AR antagonist CGP 20712A (CGP, 1 µmol/L) to stimulate the β 2 -AR, glucagon (Glu, 1 µmol/L) to stimulate Glu-R, and PGE 1 (1 µmol/L) to stimulate PGE 1 -R.
Basal cAMP was more than doubled by ISO + ICI and Glu, and increased by ≈70% by ISO + CGP. PGE 1 had no effect on cAMP content under these experimental conditions. A 15 min incubation with the broad spectrum PDE inhibitor IBMX (100 µmol/L) increased the total cAMP content by about two-fold and dramatically potentiated the response to all agonists Hal author manuscript inserm-00000047, version 1 except PGE 1 . The effect of ISO + ICI and Glu were multiplied by 8 and 7, respectively, while that of ISO + CGP was increased 3-fold. Cyclic AMP content after PGE 1 + IBMX was slightly increased when compared to IBMX alone although it did not reach statistical significance.
( Figure 2 near here)
Real-time monitoring of subsarcolemmal cAMP signals elicited by different GsPCRs in
ARVMs
To further compare cAMP signals elicited by the different receptors, we used CNG channels that allow direct monitoring of cAMP variations beneath the plasma membrane in intact ARVMs. 13 Figure 3 summarizes the results obtained with two CNGA2 mutants which differ in their sensitivity to cAMP, E583M (EC 50 for cAMP ≈10 µmol/L) and C460W/E583M (EC 50 for cAMP ≈1 µmol/L). 20 As depicted in Fig. 3A , activation of β 1 -AR by a combination of ISO (5 µmol/L) and ICI (1 µmol/L) increased basal I CNG density ≈3-fold, whereas specific activation of β 2 -AR by ISO (5 µmol/L) plus CGP (1 µmol/L) had no effect. Similarly, activation of Glu-R by Glu (1 µmol/L) or PGE 1 -R by PGE 1 (1 µmol/L) failed to activate I CNG (Fig. 3A) . These results indicate that cAMP concentration was below the activation threshold of E583M CNGA2 upon stimulation of β 2 -AR, Glu-R and PGE 1 -R. When using the C460W/E583M mutant (Fig. 3B ), activation of β 1 -AR increased basal I CNG density 6-fold.
This effect was significantly higher (p<0.01) than that obtained in cells expressing E583M CNGA2, as expected from the relative affinities of the two channels toward cAMP.
Interestingly, application of Glu now activated I CNG by approximately 5-fold, but specific activation of β 2 -AR or PGE 1 -R still had no effect. Thus, the increased sensitivity of 
Regulation of subsarcolemmal cAMP signals by PDEs
The above results suggest that cAMP signals elicited by the four different G s PCRs at the plasma membrane are not identical. We next investigated the contribution of PDEs to such specificity. Both CNGA2 mutants were used with essentially similar results, therefore the low affinity E583M channel data are presented as supplementary Figures I and II. Preliminary experiments showed that IBMX (100 µmol/L) had no significant effect on I CNG from myocytes expressing E583M/C460W (n=6, data not shown). Figure 4A shows a typical experiment in which the amplitude of I CNG is depicted as a function of time, thus providing an instant readout of subsarcolemmal cAMP level in a single cardiac myocyte. β 1 -AR stimulation with ISO (5 µmol/L) + ICI (1 µmol/L) induced a substantial increase of I CNG , which was strongly potentiated by selective PDE3 inhibition with cilostamide (Cil, 1 µmol/L) or selective PDE4 inhibition with Ro 20-1724 (Ro, 10 µmol/L). Concomitant inhibition of all PDEs with IBMX (100 µmol/L) resulted in a similar potentiation of β 1 -AR stimulation to that obtained with selective PDE4 inhibition. At the end of each experiment, the cell was challenged with a saturating concentration (100 µmol/L) of the forskolin analog L-858051 (L-85) to determine the maximal I CNG response. In Figures 4C and 4D , we investigated the role of PDEs in shaping the β 2 -AR cAMP response. As seen before, application of ISO (5 µmol/L) + CGP (1 µmol/L) had no effect on I CNG . Selective inhibition of PDE3 during β 2 -AR stimulation with ISO + CGP induced a small and transient increase of I CNG . A somewhat stronger effect was observed upon PDE4 inhibition, although it was also transient (Fig. 4C ).
In contrast, concomitant inhibition of PDE3 and PDE4 unmasked a robust and sustained cAMP increase during β 2 -AR stimulation. These results indicate that PDE3 and PDE4 control cAMP elicited by β 1 -AR and β 2 -AR. Both PDEs are necessary to circumvent the cAMP rise elicited by β 1 -AR, while either PDE3 or PDE4 individually are sufficient to prevent cAMP to rise beneath membrane upon β 2 -AR activation. 
Regulation of the L-type Ca 2+ current by GsPCRs and PDEs
Collectively, the above results show that different PDEs are involved in the regulation of cAMP generated by distinct GsPCRs in cardiac myocytes. In order to evaluate the functional implication of these findings, we examined the regulation of a major sarcolemmal cAMP target, the L-type Ca 2+ current (I Ca,L ), by GsPCRs and PDEs. The experiments were performed at 24 h, as with CNG channels experiments. Selective inhibition of PDE3 by Cil (1 µmol/L) or PDE4 by Ro (10 µmol/L) had no effect on basal I Ca,L (data not shown). This effect could be further potentiated by PDE3 inhibition with Cil and more markedly by PDE4 blockade with Ro. These results indicate that PDE3, and more prominently PDE4, are integral components of I Ca,L regulation by β 1 -AR and β 2 -AR. In another series of experiments, the regulation of I Ca,L by Glu was investigated. At high (1 µmol/L) concentration, Glu maximally stimulated I Ca,L and addition of PDE inhibitors had no effect (data not shown). At the concentration of 10 nmol/L, Glu slightly decreased I Ca,L and PDE3 inhibition by Cil had no effect. However, application of Ro to block PDE4 clearly increased I Ca,L ( Fig. 7A and 7B ).
Finally, as shown in Fig. 7C and 7D, PGE 1 had no effect on I Ca,L , even when either PDE3 or PDE4 was blocked. However, concomitant inhibition of PDE3 and PDE4 increased I Ca,L in the presence of PGE 1 , but this effect was not different from the effect of the inhibitors on the basal I Ca,L (Fig. 7D ). These results confirm the specific and functional coupling of Glu-R to 
Discussion
While a number of recent studies have underscored the role of PDEs in tailoring hormonal cAMP signals, [9] [10] [11] [12] [13] [21] [22] [23] none has addressed directly whether distinct hormonal cAMP signals are controlled by different PDEs. To gain some insight into this question, we used complementary biochemical and electrophysiological techniques to resolve cAMP at the cellular, subsarcolemmal and local levels. We show that four canonical G s PCRs expressed in ARVMs generate different cAMP signals due to a specific contribution of individual PDE families. For all receptors but PGE 1 -R, the nature of this functional coupling determines the regulation of a major downstream cAMP target, the L-type Ca 2+ channels.
In agreement with previous studies, we found that PDE3 and PDE4 represent the major cAMP hydrolytic activities in rodent cardiomyocytes. 12, 13, 24 While there is a general agreement that β 1 -AR increases cAMP in adult rat cardiac preparations, 3,25-27 the ability of β 2 -AR to do so is a matter of debate. 3, 25, 26 Although glucagon increases cAMP in various cardiac preparations, 4 recent studies failed to detect it. 27,28 . Thus, we checked whether stimulation of the different receptors led to detectable increases in total cAMP in ARVMs. We found that stimulation of β 1 -AR, Glu-R, and to a lesser extent β 2 -AR, increased total cAMP content, and that IBMX greatly accentuated these effects. In contrast, PGE 1 alone did not increase cAMP, although a small effect could be observed in the presence of IBMX. This result is at variance with those from Buxton & Brunton 29 in rabbit cardiomyocytes, where ISO and PGE 1 similarly increased cAMP. However, in addition to species differences, the experimental conditions used here are different, as PGE 1 was used at a 10-fold lower concentration (1 vs. 10 µmol/L) and application lasted 5-fold less (3 vs. 15 min).
We next used CNG channels to monitor cAMP signals triggered by distinct routes near the plasma membrane. 11, 13 We found that activation of β 1 -AR and Glu-R elicit readily detectable cAMP at the membrane, whereas β 2 -AR and PGE 1 -R do not. In heterologous expression systems and in rat olfactory epithelium, CNG channels associate preferentially with non-caveolar lipid rafts. 30 If this holds true in ARVMs, failure to detect cAMP elicited by β 2 -AR and PGE 1 -R could be due to localization of these receptors in caveolae. [31] [32] [33] [34] However, this localization does not prevent cAMP diffusion to CNG channels when PDEs are inhibited Indeed, we found that IBMX, at 100 µmol/L concentration, increased the response of I CNG not only to β 1 -AR and Glu-R stimulation, but also revealed cAMP generated by β 2 -AR and PGE 1 -R stimulation. Given the K i of IBMX for the different PDEs, 35 100 µmol/L of this inhibitor should block most of the PDE activity, PDE1, PDE2, PDE3 and PDE4 being inhibited by ≈98%, ≈93%, ≈97% and ≈87%, respectively. To delineate the specific contribution of PDE4, we used Ro 20-1724, which at 10 µmol/L should inhibit ≈71% of its activity without affecting the other PDEs. 35 We found that PDE4 hydrolyzes cAMP produced by all the receptors tested, thus limiting PKA activation and Ca 2+ channel phosphorylation upon β 1 -AR, β 2 -AR and Glu-R activation. These results are consistent with previous studies showing that PDE4 is critically involved in the regulation of I Ca,L and contractility by catecholamines and glucagon. 21,28,36 PDE4 isoforms are likely to play this ubiquitous role due to their molecular diversity and specific subcellular localization. [37] [38] [39] However, whether specific PDE4 isoforms are associated with different receptors remains unclear. Recent data in neonatal cardiomyocytes reported an important role for PDE4B2 in controlling norepinephrine-induced cAMP increase. 12 However, in the same model, other studies suggest that PDE4D isoforms are preferentially associated with the β 2 -AR. For instance, PDE4D5 and to a lesser extent PDE4D3 are recruited to the β 2 -AR by β-arrestin upon ISO challenge. 22, 40 Moreover, Xiang et al. (2005) 16 showed that PDE4D selectively affects β 2 -AR vs. β 1 -AR positive chronotropism. Whether these findings apply to ARVMs remains to be established. Nearly complete (≈95%) and selective PDE3 inhibition should be achieved by 1 µmol/L cilostamide 35 . Using this inhibitor, we found that PDE3 controls the cAMP signals generated by β 1 -AR, β 2 -AR and PGE 1 -R, but not Glu-R. However, on I Ca,L response, PDE3 controlled the effects of β 1 -AR and β 2 -AR, but had no impact on Glu-R or PGE 1 -R stimulation. We showed previously that PDE3 controlled cAMP diffusion and consequently I Ca,L activation in cardiac myocytes subjected to β−adrenergic stimulation. 13, 21, 36, 41, 42 Our findings contrast with results obtained in neonatal rat ventricular myocytes where PDE3 was found to have a moderate effect on β 1 -AR (with norepinephrine) induced cAMP. 12 Moreover, in right ventricular strips from adult rat, PDE3 inhibition had no effect on the contractile response to the β 1 -AR agonist dobutamine but potentiated that of glucagon. 27 In parallel cAMP assays, these authors found that PDE3 inhibition had also no effect on the response to dobutamine but revealed a substantial cAMP increase caused by glucagon. While obvious differences in developmental stage, cardiac territory or rat strains might account for some of the discrepancies, one should emphasize that CNG channels provide a readout of subsarcolemmal cAMP, while other methods measure cytosolic or total cAMP. Thus, one could speculate that upon β 1 -AR stimulation, PDE3 controls the membrane cAMP pool but not a cytosolic one, possibly involved in contractility (sarcoplasmic reticulum-associated PDE3 for instance 43 ). In the case of Glu-R, the opposite would be true: PDE3 would not control subsarcolemmal cAMP generated by Glu-R, but would prevent the access of the second messenger to other, non sarcolemmal inotropic targets. For such a hypothesis to be valid, one must further speculate either that totally segregated cAMP pathways are triggered by the different receptors (including PKA targets), or that differential regulation of PDE3 is triggered by receptor activation. The latter mechanisms was found in frog heart but not in rat. 44 decreased while PDE4D was unchanged. 46 In the same model, a modest reduction in total PDE activity was found in the left ventricular subendocardium but not in the epicardium, suggesting regional differences. 47 In human, sarcoplasmic reticulum-associated PDE3 activity was shown to be unchanged in heart failure, 43 although total PDE3 activity appears reduced and PDE3A protein expression down-regulated in end-stage failing human heart. 48 In rat, the expression and activity of PDE3 and PDE4 are strongly augmented in hypertension-induced hypertrophy. 49 Finally, a recent study shows that PDE4D deficiency favours ryanodine receptors aberrant phosphorylation and promotes heart failure in mice. 50 Although more work is needed to obtain a clear picture of the PDE rearrangement occurring in hypertrophy and heart failure, this study suggests that PDE alteration may affect cAMP compartmentation, leading to untargeted hormonal cAMP signals, aberrant phosphorylation of targets proteins and, in fine, contribute to cardiac dysfunction. Electrophysiological Experiments -The whole-cell configuration of the patch-clamp technique was used to record the L-type calcium current (I Ca,L ) and the CNG current (I CNG ), as previously described. 2 For I Ca,L measurement, the cells were depolarized every 8 seconds to 0 mV during 400 ms. Fast sodium current was inactivated by holding potential (-50 mV) and potassium currents were blocked by replacing all K + ions with external and internal Cs + . For I CNG measurement, the cells were maintained at 0 mV holding potential and routinely hyperpolarized every 8 seconds to -50 mV test potential during 200 ms. The 0 mV holding potential was chosen because it corresponds to the reversal potential of I CNG under our experimental conditions. I CNG was recorded in the absence of divalent cations in the extracellular solution allowing monovalent cations to flow through the channels in an unspecific manner. All the experiments were done at room temperature (21-27°C), and the temperature did not vary by more than 1°C in a given experiment. Figure II 
Figure legends
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